StonvexLoading…
StonvexStonvexStonvexCore line items from GCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|---|
Revenue | $381.02M | $359.49M | $1.29B | $271.91M | $1.16B |
Operating Income | Not available | $42.48M | $144.98M | $28.32M | $130.62M |
Net Income | Not available | $38.12M | $137.37M | $27.15M | $125.81M |
EPS (Diluted) | $0.82 | $1.04 | $3.59 | $0.68 | $3.05 |
Total Assets | Not available | $1.23B | $1.20B | $1.09B | $1.07B |
Total Liabilities | Not available | $719.92M | $716.66M | $678.14M | $665.26M |
Cash & Equivalents | Not available | $330.27M | $379.78M | $251.71M | $259.76M |
Free Cash Flow OCF − CapEx | Not available | $-26.20M | $182.79M | $7.04M | $142.54M |
Shares Outstanding | Not available | 36.77M | 38.23M | 40.14M | 41.20M |